Sailing into the IO headwind

Figuring out how to combine different IO approaches will take time so what have we learned lately?

March 7, 2019

Sorting signals from the noise

PARP plus IO and IO combos are becoming all the rage, what can we learn from early signals?

March 5, 2019

How Will Adoptive Cell Therapy Crack Solid Tumours?

A look at Dr Malcolm Brenner's work on virus specific T cell therapies

January 31, 2018

Report on key data in GU Cancers from ASCO-SITC 2018

At ASCO-SITC this weekend there was some compelling new scientific data highlighting subsets of patients who might be eligible for cancer immunotherapy, including novel combination approaches.

January 30, 2018

Important ASCO-SITC 2017 Highlights and Trends

6 key trends and highlights of note from the inaugural ASCO-SITC meeting in Orlando, Florida

March 3, 2017

Novel Way to Improve Checkpoint Inhibitor Efficacy

A look at another surprising factor that might affect efficacy of cancer immunotherapy and checkpoint blockade.

March 1, 2017

A novel immune checkpoint target

After JAK1/2 upregulation and PTEN loss, a third mechanism of resistance to checkpoint blockade has been identified. We discuss the issues around this latest challenge...

February 28, 2017